Australia markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.11-0.48 (-7.28%)
As of 01:28PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
21,281
18,496
21,301
10,682
Selling general and administrative
13,427
13,796
10,574
8,012
Total operating expenses
34,512
31,797
31,787
18,694
Operating income or loss
-34,512
-31,797
-31,787
-18,694
Total other income/expenses net
-
-
696.714
-
Income before tax
-34,447
-31,770
-31,039
-18,567
Income from continuing operations
-34,447
-31,770
-31,039
-18,567
Net income
-34,447
-31,770
-31,039
-18,567
Net income available to common shareholders
-34,447
-31,770
-31,039
-18,567
Basic EPS
-12.75
-26.50
-31.25
-22.75
Diluted EPS
-12.75
-26.50
-31.25
-22.75
Basic average shares
1,637
1,199
992.838
817.006
Diluted average shares
1,637
1,199
992.838
817.006